UK approves Oxford Covid-19 vaccines for use
London: The UK on Wednesday approved the Oxford University-AstraZenecas Covid-19 vaccine for use after authorisation by the country's medicines regulator. The...
COVID-19
Covaxin can deal with new Covid strains too: Bharat Biotech
Hyderabad: Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will be effective in dealing with new strains of coronavirus....
COVID-19: At 16K, India records lowest new cases since June-end
New Delhi: India on Monday logged 16,432 fresh Covid-19 infections which is 500 less than what it recorded in the past...
India records 18.7K new Covid cases in last 24 hours; lowest in 6 months
New Delhi: India on Sunday recorded 18,732 fresh Covid-19 infections and 279 deaths in the last 24 hours taking the total...
After crossing 1 crore-mark, India reports 26K new Covid cases
New Delhi: With 26,594 new coronavirus cases and 341 deaths in the past 24 hours, India's overall tally stood at 1,00,31,193...
India requires Rs 80,000 crore for vaccine distribution next year: SII
New Delhi: Pune-based vaccine-maker Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, on Saturday said...
India to produce 300mn doses of Sputnik V vaccine in 2021: Report
Moscow: India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, the head of the...
Smell & taste loss first Covid infection symptom: Study
London: Loss of smell and taste are common in people who have Covid-19 infections and now a new study found that...
AstraZeneca vaccine 70.4% effective at preventing Covid-19
New Delhi (3 Min Read): Results of an interim analysis of the Phase III programme conducted by Oxford University with AZD1222,...
Phase 2 and 3 clinical trials for Sputnik vaccine commence
New Delhi (1 Min Read): Dr. Reddys Laboratories Ltd. and Russian Direct Investment Fund (RDIF) announced on Tuesday that they have...
